Hyperemesis gravidarum is associated with increased maternal serum ischemia-modified albumin

References

[1] McCarthy FP, Lutomski JE, Greene RA. Hyperemesis gravidarum: current perspectives. Int J Womens Health. 2014;6:719–25.10.2147/IJWH.S37685Search in Google Scholar PubMed PubMed Central

[2] World Health Organization. International statistical classification of diseases and related health problems. 10th Rev. World Health Organization, 2007. Available at: http://apps.who.int/classifications/apps/icd/icd10online2007/. Accessed April 15, 2013.Search in Google Scholar

[3] Wood H, McKellar LV, Lightbody M. Nausea and vomiting in pregnancy: blooming or bloomin’ awful? A review of the literatüre. Women Birth. 2013;26:100–4.10.1016/j.wombi.2012.10.001Search in Google Scholar PubMed

[4] Vikanes AV, Stoer NC, Magnus P, Grjibovski AM. Hyperemesis gravidarum and pregnancy outcomes in the Norwegian Mother and Child Cohort – a cohort study. BMC Pregnancy Childbirth. 2013;13:169.10.1186/1471-2393-13-169Search in Google Scholar PubMed PubMed Central

[5] Mullin PM, Ching C, Schoenberg F, MacGibbon K, Romero R, Goodwin TM, et al. Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2012;25:632–6.10.3109/14767058.2011.598588Search in Google Scholar PubMed PubMed Central

[6] McCarthy FP, Khashan AS, North RA, Moss-Morris R, Baker PN, Dekker G, et al. A prospective cohort study investigating associations between hyperemesis gravidarum and cognitive, behavioural and emotional well-being in pregnancy. PLoS One. 2011;6:e27678.10.1371/journal.pone.0027678Search in Google Scholar PubMed PubMed Central

[7] Caglayan EK, Engin-Ustun Y, Gocmen AY, Sarı N, Seckin L, Kara M, et al. Is there any relationship between serum sirtuin-1 level and neutrophil-lymphocyte ratio in hyperemesis gravidarum? J Perinat Med. 2016;44:315–20.10.1515/jpm-2015-0178Search in Google Scholar PubMed

[8] Zhou Q, O’Brien B, Relyea J. Severity of nausea and vomiting during pregnancy: what does it predict? Birth. 1999;26: 108–14.10.1046/j.1523-536x.1999.00108.xSearch in Google Scholar PubMed

[9] Shen XL, Lin CJ, Han LL, Lin L, Pan L, Pu XD. Assessment of ischemia-modified albumin concentrations for emergency room diagnosis of acute coronary syndrome. Int J Cardiol. 2011;149:296–8.10.1016/j.ijcard.2010.01.013Search in Google Scholar PubMed

[10] Van Rijn BB, Franx A, Sikkema JM, van Rijn HJ, Bruinse HW, Voorbij HA. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy. 2008;27:159–67.10.1080/10641950701885147Search in Google Scholar PubMed

[11] Papageorghiou AT, Prefumo F, Leslie K, Gaze DC, Collinson PO, Thilaganathan B. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod. 2008;23:803–6.10.1093/humrep/den029Search in Google Scholar PubMed

[12] Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol. 2003;162:115–25.10.1016/S0002-9440(10)63803-5Search in Google Scholar

[13] Prefumo F, Gaze DC, Papageorghiou AT, Collinson PO, Thilaganathan B. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia – ischaemia-driven early trophoblast development. Human Reprod. 2007;22:2029–32.10.1093/humrep/dem095Search in Google Scholar

[14] Sullıvan CA, Johnson CA, Roach H, Martın RW, Stewart DK, Morrıson JC. A pilot study of intravenous ondansetron for hyperemesis gravidarum. Am J Obstet Gynecol. 1996;174: 1565–8.10.1016/S0002-9378(96)70607-5Search in Google Scholar

[15] Engin-Ustun Y, Tonguç E, Var T, Deveer R, Yilmaz N, Danisman N, et al. Vaspin and C-reactive protein levels in hyperemesis gravidarum. Eur Rev Med Pharmacol Sci. 2013;17:138–40.Search in Google Scholar

[16] Rossi A, Bortolotti N, Vescovo S, Romanello I, Forzano L, Londero AP, et al. Ischemia-modified albumin in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2013;170:348–51.10.1016/j.ejogrb.2013.06.037Search in Google Scholar PubMed

[17] Sari K, Gencer ZK, Ede H, Gocmen AY, Kantekin Y. Ischemia-modified albumin, brain natriuretic peptide, and growth differentiation factor-15 levels in patients with nasal polyps. Auris Nasus Larynx. 2016;43:529–36.10.1016/j.anl.2015.12.009Search in Google Scholar PubMed

[18] Guven S, Alver A, Mentese A, Ilhan FC, Calapoglu M, Unsal MA. The novel ischemia marker ‘ischemia-modified albumin’ is increased in normal pregnancies. Acta Obstet Gynecol Scand. 2009;88:479–482.10.1080/00016340902777517Search in Google Scholar PubMed

[19] Yilmaz S, Ozgu-Erdinc AS, Demirtas C, Ozturk G, Erkaya S, Uygur D. The oxidative stress index increases among patient with hyperemesis gravidarum but not in normal pregnancies. Redox Rep. 2015;20:97–102.10.1179/1351000214Y.0000000110Search in Google Scholar PubMed PubMed Central

[20] Longini M, Perrone S, Kenanidis A, Vezzosi P, Marzocchi B, Petraglia F, et al. Oxidative stress in amniotic fluid of pregnancies with fetal growth retardation. Pediatr Res. 2004;56:471.10.1203/00006450-200409000-00067Search in Google Scholar

[21] Ustün Y, Engin-Ustün Y, Oztürk O, Alanbay I, Yaman H. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J. Matern Fetal Neonatal Med. 2011;24:418–21.10.3109/14767058.2010.497879Search in Google Scholar PubMed

[22] Ozdemir S, Kiyici A, Balci O, Goktepe H, Cicekler H, Celik C. Assessment of ischemia-modified albumin level in patients with recurrent pregnancy loss during the first trimester. Eur J Obstet Gynecol Reprod Biol. 2011;155:209–12.10.1016/j.ejogrb.2010.12.004Search in Google Scholar PubMed

[23] Cengiz H, Dagdeviren H, Kanawati A, Suzen Çaypinar S, Yesil A, Ekin M, et al. Ischemia-modified albumin as an oxidative stress biomarker in early pregnancy loss. J Matern Fetal Neonatal Med. 2016;29:1754–7.10.3109/14767058.2015.1061494Search in Google Scholar PubMed

[24] Sanu O, Lamont RF. Hyperemesis gravidarum: pathogenesis and the use of antiemetic agents. Exp Opin Pharmacother. 2011;12:737–48.10.1517/14656566.2010.537655Search in Google Scholar PubMed